Hypertension Clinical Trial
— BAHOfficial title:
Effect of Recreational Beach Tennis on Ambulatory Blood Pressure and Physical Fitness in Hypertensive Individuals (BAH Study)
Verified date | February 2024 |
Source | Hospital de Clinicas de Porto Alegre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
No studies have investigated the chronic effects of team sports on 24 h ambulatory blood pressure and have assessed the effects of a beach tennis intervention in cardiovascular profile and physical fitness. Based on that, the investigators designed this parallel randomized controlled trial to evaluate the effect of beach tennis training on 24 h ambulatory blood pressure and different physical fitness parameters in individuals with hypertension. The difference between the intervention arms in mean change from baseline in 24 h, daytime and nighttime systolic and diastolic ambulatory blood pressure at 12-weeks is the primary outcome; secondary outcomes are the difference between mean change in office blood pressure as well as cardiorespiratory fitness, muscular strength and power. The investigators anticipate that 12 weeks of beach tennis training will reduce blood pressure when compared to a non-exercising control group. Additionally, our recreational beach tennis intervention will improve all physical fitness components in comparison to the baseline values.
Status | Active, not recruiting |
Enrollment | 42 |
Est. completion date | March 1, 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years to 65 Years |
Eligibility | Inclusion Criteria: - Office blood pressure between 130-179 and 80-110 mmHg for systolic and diastolic blood pressure, respectively; - Non-engaged in structured exercise programs in the last 3 months before the beginning of this study; - Able to perform the proposed exercises. Exclusion Criteria: - Underlying cardiovascular disease in the last 24 months such as acute myocardial infarction, angina, stroke or heart failure; - Diseases that reduce life expectancy; - Smokers; - BMI >39.9 kg/m²; - Diabetic proliferative retinopathy. |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital de Clinicas de Porto Alegre | Porto Alegre | RS |
Lead Sponsor | Collaborator |
---|---|
Hospital de Clinicas de Porto Alegre | Federal University of Rio Grande do Sul |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ambulatory Blood Pressure | 24h ambulatory blood pressure measured through automatic oscillometric device | Change from baseline 24-hour systolic blood pressure at 12 weeks | |
Secondary | Systolic blood pressure | Systolic blood pressure in mmHg measured using automatic oscillometric device | Will be measured during intervention period throughout the first session of weeks 1, 4, 5, 8, 9 and 12. | |
Secondary | Diastolic blood pressure | Diastolic blood pressure in mmHg measured using automatic oscillometric device | Will be measured during intervention period throughout the first session of weeks 1, 4, 5, 8, 9 and 12. | |
Secondary | Cardiorespiratory fitness (Oxygen consumption at peak) | Oxygen consumption at peak (VO2peak) as assessed by maximal cardiopulmonary exercise testing | Change from baseline VO2peak at 12 weeks | |
Secondary | Muscle strength (Test of hand grip strength) | Performs palmar grip with the greatest possible force | Change from baseline handgrip at 12 weeks | |
Secondary | Muscle strength (Chair-stand test) | The total number of stands executed correctly within 30-s | Change from baseline Chair-stand test at 12 weeks | |
Secondary | Muscle strength (Chair-stand test) | The time to perform the first five stands executed correctly | Change from baseline Chair-stand test at 12 weeks | |
Secondary | Power muscle | Vertical countermovement jump tests | Change from baseline vertical countermovement jump at 12 weeks | |
Secondary | Quality of life (WHOQOL-BREF questionnaire) | The questionnaire contains 26 questions and is divided into four domains (physical, psychological, social and environmental). Responses follow a Likert scale (1 to 5, the higher the score the better the quality of life) and the values of each domain will be expressed in percentage values. | Change from baseline QoL score at 12 weeks | |
Secondary | Enjoyment (PACES questionnaire) | The scale is composed of 18 items in a bipolar affirmations format (i.e., "amused" versus "not-amused") punctuated in a range from the minimum value "1" to the maximum value "7". | Will be measured during intervention period throughout the first session of weeks 1, 4, 5, 8, 9 and 12. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |